Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
Recruiting · NCT07529847 · Interventional (participants receive a specific treatment) · Lead sponsor: Foundation University Islamabad
View the official record on ClinicalTrials.gov →Interventions studied
Alternative Nostril Breathing Technique along with standard pharmacological managementButeyko breathing along with pharmacological management
What this trial is about
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
Who can take part
Age range
18 Years to 45 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age between 18-45 years
- Both genders (male and female)
- Grade 1-3 on mMRC scale of dyspnea
- Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020)
Exclusion criteria
- Patients having acute exerbation of COPD/status asthmaticus
- Patients diagnosed with acute infection
- Patients unable to follow command and instructions
- Asthma patients with \>40sec control pause duration
Where it is running
1 location listed.
- Foundation University Islamabad - Islamabad, Pakistan